Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,583 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant chemotherapy for muscle-invasive bladder cancer: does variant histology matter?
Catarino R, Alves L, Pereira D, Costa G, Pereira J, Cardoso A, Braga I, Freitas R, Correia T, Cerqueira M, Reis FC, Lobo F, Silva V, Magalhães S, Morais A, Prisco R. Catarino R, et al. Among authors: freitas r. Int Urol Nephrol. 2022 Dec;54(12):3163-3169. doi: 10.1007/s11255-022-03358-3. Epub 2022 Sep 5. Int Urol Nephrol. 2022. PMID: 36063276
Parcial Nephrectomies - results of 12 years from an Oncology Institution.
Freitas R, Cruz R, Antunes L, Araújo P, Silva P, Saraiva L, Magalhães S, Moreira Silva V, Morais A, Lobo F, Oliveira J. Freitas R, et al. Acta Med Port. 2016 Feb;29(2):123-30. doi: 10.20344/amp.5231. Epub 2016 Feb 29. Acta Med Port. 2016. PMID: 27234952 Free article.
Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer.
Ferreira E, Ferreira D, Relvas-Santos M, Freitas R, Soares J, Azevedo R, Afonso LP, Lima L, Santos B, Gonçalves M, Silva AMN, Santos LL, Peixoto A, Ferreira JA. Ferreira E, et al. Among authors: freitas r. Int J Mol Sci. 2024 Mar 19;25(6):3462. doi: 10.3390/ijms25063462. Int J Mol Sci. 2024. PMID: 38542435 Free PMC article.
Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases.
Lima L, Neves M, Oliveira MI, Dieguez L, Freitas R, Azevedo R, Gaiteiro C, Soares J, Ferreira D, Peixoto A, Fernandes E, Montezuma D, Tavares A, Ribeiro R, Castro A, Oliveira M, Fraga A, Reis CA, Santos LL, Ferreira JA. Lima L, et al. Among authors: freitas r. Urol Oncol. 2017 Dec;35(12):675.e1-675.e8. doi: 10.1016/j.urolonc.2017.08.012. Epub 2017 Sep 12. Urol Oncol. 2017. PMID: 28911924
MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors.
Torres-Ferreira J, Ramalho-Carvalho J, Gomez A, Menezes FD, Freitas R, Oliveira J, Antunes L, Bento MJ, Esteller M, Henrique R, Jerónimo C. Torres-Ferreira J, et al. Among authors: freitas r. Mol Cancer. 2017 Jan 31;16(1):26. doi: 10.1186/s12943-017-0604-0. Mol Cancer. 2017. PMID: 28143614 Free PMC article.
1,583 results